Effect of intravenous nimodipine on blood pressure and outcome after acute stroke
2000 (English)In: Stroke, ISSN 0039-2499, E-ISSN 1524-4628, Vol. 31, no 6, 1250-1255 p.Article in journal (Refereed) Published
Background and Purpose-The Intravenous Nimodipine West European Stroke Trial (INWEST) found a correlation between nimodipine-induced reduction in blood pressure (BP) and an unfavorable outcome in acute stroke. We sought to confirm this correlation with and without adjustment for prognostic variables and to investigate outcome in subgroups with increasing levels of BP reduction. Methods-Patients with a clinical diagnosis of ischemic stroke (within 24 hours) were consecutively allocated to receive placebo (n=100), 1 mg/h (low-dose) nimodipine (n=101), or 2 mg/h (high-dose) nimodipine (n=94). The correlation between average BP change during the first 2 days and the outcome at day 21 was analysed. Results-Two hundred sixty-five patients were included in this analysis (n=92, 93, and 80 for placebo, low dose, and high dose. respectively). Nimodipine treatment resulted in a statistically significant reduction in systolic BP (SBP) and diastolic BP (DBP) from baseline compared with placebo during the first few days. In multivariate analysis, a significant correlation between DBP reduction and worsening of the neurological score was round for the high-close group (beta=0.49, P=0.048). Patients with a DBP reduction of greater than or equal to 20% in the high-dose group had a significantly increased adjusted OR for the compound outcome variable death or dependency (Barthel Index <60) (n/N=25/26, OR 10.16, 95% CI 1.02 to 101.74) and death alone (n/N=9/26, OR 4.3361 95% CI 1.131 16.619) compared with all placebo patients (n/N=62/92 and 14/92. respectively). There was no correlation between SEP change and outcome. Conclusions-DBP, but not SEP, reduction was associated with neurological worsening after the intravenous administration of high-dose nimodipine after acute stroke. For low-dose nimodipine, the results were not conclusive. These results do not confirm or exclude a neuroprotective property of nimodipine.
Place, publisher, year, edition, pages
2000. Vol. 31, no 6, 1250-1255 p.
blood pressure, cerebral ischemia, nimodipine, stroke, acute, acute ischemic stroke, cerebrovascular-disease, cerebral infarction, glucose-metabolism, controlled trial, hypertension, flow, thresholds, tomography, treat
IdentifiersURN: urn:nbn:se:kth:diva-19793ISI: 000087335200008OAI: oai:DiVA.org:kth-19793DiVA: diva2:338485
QC 201005252010-08-102010-08-102010-09-01Bibliographically approved